SCHEDULE: FMR LLC and Abigail Johnson Maintain Significant 10.5% Stake in Lexicon Pharmaceuticals
Ownership Disclosure
FMR LLC and Abigail P. Johnson have disclosed a combined beneficial ownership of 10.5% of Lexicon Pharmaceuticals Inc.'s common stock, totaling 38,137,535 shares, as of June 30, 2025.
Summary
- FMR LLC and Abigail P. Johnson collectively beneficially own 38,137,535 shares of Lexicon Pharmaceuticals Inc. common stock.
- This ownership represents 10.5% of the total outstanding common stock of Lexicon Pharmaceuticals Inc.
- FMR LLC holds sole voting power over 38,112,677 shares and sole dispositive power over 38,137,535 shares.
- Abigail P. Johnson holds sole dispositive power over 38,137,535 shares.
- The shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Lexicon Pharmaceuticals Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently be considered positive or negative for the issuer's operational or financial performance.
Future Outlook
No forward-looking statements or guidance regarding Lexicon Pharmaceuticals Inc. are provided in this ownership disclosure.
Industry Context
This filing is a routine disclosure of institutional ownership, common in the financial industry, and does not provide specific insights into broader industry trends or competitive landscape for Lexicon Pharmaceuticals Inc.
Stakeholder Impact
- Shareholders: This filing confirms the continued significant institutional ownership by FMR LLC and Abigail P. Johnson, providing transparency regarding a major shareholder's stake.
Key Dates
| Date | Description |
|---|---|
| 01/03/2023 | Effective date of Power of Attorney for FMR LLC. |
| 01/26/2023 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 06/30/2025 | Date of event which requires the filing of this statement. |
| 07/07/2025 | Date of filing of this Schedule 13G Amendment No. 3. |
Keywords
Lexicon Pharmaceuticals, FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.